BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Texas Heart Institute and MicroMed Cardiovascular Announce Achievement of World Record of an Animal Supported by an Electronic Total Artificial Heart


12/1/2011 9:30:00 AM

HOUSTON, TX--(Marketwire - December 01, 2011) - Texas Heart Institute and MicroMed Cardiovascular, Inc. announced today, during the opening of the 6th Annual European Mechanical Circulatory Support Summit in Paris, a new record has been established for an animal supported by an Electronic, Continuous Flow, Total Artificial Heart. A calf was successfully supported for 91 days by two modified HeartAssist 5® Continuous Flow LVADs, manufactured by MicroMed Cardiovascular, Inc. of Houston, TX, USA, under a special NIH Research Grant to advance Total Artificial Heart Technology. This achievement broke the previous record for continuous flow total artificial heart animal support of 60 days, also at Texas Heart Institute, and using two modified HeartAssist 5® LVADS earlier this year.

Dr. Bud Frazier, together with Dr. Billy Cohn of the Center for Cardiac Support at Texas Heart Institute, commented, "The Study Protocol defines success at 60 days but this calf did so well we modified the protocol to extend the protocol to 90 days and are very pleased with the results." David Mackstaller, CEO for MicroMed Cardiovascular, Inc., commented, "We have worked with Texas Heart Institute for many years and we are excited to have contributed to this important milestone. We remain firmly committed to advancements in mechanical support to ultimately make a difference in restoring the lives of patients suffering from heart failure around the world."




Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES